News April 26, 2021 Creating Your SBIR/STTR Cost Proposal | SBIR.gov This half-day workshop, led by Jim Greenwood of Greenwood Consulting Group will cover one of… Super User Love0
News April 26, 2021 UpSurge Baltimore aims to turn Baltimore into a top-tier tech city, with equity in mind – Baltimore Business Journal UpSurge Baltimore will aim to bolster existing efforts to support and scale local startups, and… Super User Love0
News April 26, 2021 NL Health~Holland | International opportunities for pharma business – TFHC (Bendis Speaking) Did you take the step to go across the border with your organization? Or do… Super User Love0
News April 26, 2021 We’re Open for Business! A First Sneak Peek of JLABS @ Washington, DC – Blog Post | JLABS Johnson & Johnson Innovation – JLABS @ Washington, DC: We did it! Persevering through a… Super User Love0
News April 23, 2021 Johns Hopkins teams take top prizes at business analytics competition | Hub For the second consecutive year, a team of Johns Hopkins students from the Carey Business… Super User Love0
News April 23, 2021 Addressing the needs of pediatric medicine with the Children’s Hospital Coalition powered by Phlow RICHMOND, Va. -- The pandemic has created an ongoing need for pediatric medicine and two… Super User Love0
News April 23, 2021 Events – Alliance of Merger & Acquisition Advisors AM&AA brings back the world of middle-market mergers and acquisitions live and in-person this summer in Dallas,… Super User Love0
News April 23, 2021 Immunomic Therapeutics Announces License Agreement With Lineage Cell Therapeutics for Cancer Immunotherapy – Immunomic Therapeutics ROCKVILLE, Md. & CARLSBAD, Calif.–(BUSINESS WIRE)– Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical stage biotechnology… Super User Love0
News April 23, 2021 Biotech accelerator finishes construction, begins looking for tenants – Inside Business A Virginia Beach biotech accelerator program announced more than five years ago as a way… Super User Love0
News April 23, 2021 Gain Therapeutics – Gain Therapeutics Announces Multi-Target Drug Discovery Collaboration Agreement with Zentalis Pharmaceuticals Collaboration to use Gain’s proprietary Site-Directed Enzyme Enhancement Therapy (SEE-Tx™) computational platform technology to identify… Super User Love0